(One hundred posts! Including referrals to previous posts! And it only took a little over eleven years! Woo hoo!)
Reports are coming out that one of the several proposed treatments for COVID-19 will be a "Multistem" stem-cell therapy from Athersys, a company that works with adult stem cells. According to its site,
"We are developing MultiStem®, a patented, adult-derived 'off-the-shelf' stem cell therapy platform, for disease indications in areas of neurological, inflammatory & immune, and cardiovascular disease areas, as well as other critical care indications where there is substantial unmet medical need due to the limitations in standard of care."
Adult stem cells, a topic of many posts (of the one hundred) in the history of Benevolent Grammarian, are derived from actual adults, born children, or umbilical-cord blood. For many years, while embryo-destructive stem-cell research was being hyped by the media, adult stem cells -- which have already been used successfully to treat patients in the fight against 73 different diseases and ailments -- were often given short shrift or ignored outright. As with other potential remedies for COVID-19, we'll keep our eyes on this one...
No comments:
Post a Comment